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Abstract
Common genetic variants at the RIN3 locus on chromosome 14q32 predispose to Paget’s disease of bone (PDB) but the 
mechanisms by which they do so are unknown. Here, we analysed the skeletal phenotype of female mice with targeted inac-
tivation of the mouse Rin3 gene (Rin3−/−) as compared with wild-type littermates. The Rin3−/− mice had higher trabecular 
bone volume (BV/TV%) compared with wild type. Mean ± standard deviation values at the distal femur at 8 weeks were 
9.0 ± 2.5 vs. 7.0 ± 1.5 (p = 0.002) and at 52 weeks were 15.8 ± 9.5 vs. 8.5 ± 4.2 (p = 0.002). No differences were observed 
in femoral cortical bone parameters with the exception of marrow diameter which was significantly smaller in 52-week-old 
Rin3−/− mice compared to wild type: (0.43 mm ± 0.1 vs. 0.57 mm ± 0.2 (p = 0.001). Bone histomorphometry showed a 
lower osteoclast surface / bone surface (Oc.S/BS%) at 8 weeks in Rin3−/− mice compared to wild type (24.1 ± 4.7 vs. 29.7 
± 6.6; p = 0.025) but there were no significant differences in markers of bone formation at this time. At 52 weeks, Oc.S/BS 
did not differ between genotypes but single labelled perimeter (SL.Pm/B.Pm (%)) was significantly higher in Rin3−/− mice 
(24.4 ± 6.4 vs. 16.5 ± 3.8, p = 0.003). We conclude that Rin3 negatively regulates trabecular bone mass in mice by inhibiting 
osteoclastic bone resorption and favouring bone formation. Our observations also suggest that the variants that predispose 
to PDB in humans probably do so by causing a gain-in-function of RIN3.
Keywords Paget’s disease · Osteoclast · Genetic · RIN3
Introduction
Paget’s disease of bone (PDB) is characterised by increased 
bone remodelling at one or more skeletal sites. It is thought 
that the primary pathogenic event in PDB is increased osteo-
clast activity, but this is accompanied by increased and dis-
organised bone formation. Genetic factors play a key role in 
the pathogenesis of PDB, but environmental triggers also 
play a role as reflected by a reduction in the prevalence and 
severity of PDB in many countries over recent decades [1]. 
Genome-wide association studies (GWAS) have so far iden-
tified six loci that predispose to PDB at a genome-wide sig-
nificant level [2, 3], and additional predisposing genes have 
been identified by linkage analysis and genome sequenc-
ing in families [4–6]. A locus on chromosome 14q32 was 
found to predispose to PDB by an extended GWAS [2]. The 
strongest association was observed with rs10498635 which 
is situated close to the RIN3 gene, encoding the Ras and 
Rab interactor protein 3 [7]. The rs10498635 variant lies 
outside the gene but is in strong linkage disequilibrium with 
an arginine to cysteine amino acid change at position 279 
(R279C) of the protein [2]. Subsequent mutation screen-
ing of RIN3 identified several other protein coding variants 
that were associated with PDB which cluster in a proline-
rich domain of the protein [8]. In another study of Belgian 
PDB patients and controls, de Ridder and colleagues [9] 
confirmed evidence of association between variants at the 
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RIN3 locus and PDB and identified several rare potentially 
deleterious coding variants that were associated with the 
disease. While the role of Ras and Rab interactor 3 in bone 
metabolism remains unclear, it is a guanine exchange factor 
for small GTPases which are known play a role in vesicular 
trafficking and other processes relevant to osteoclastic bone 
resorption [10, 11]. With this background, the aim of the 
present study was to gain an insight into the role of RIN3 in 
skeletal homeostasis by conducting skeletal phenotyping of 
mice with targeted inactivation of the Rin3 gene.
Materials and Methods
Animals
Mice with targeted inactivation of Rin3 (Rin3−/−), generated 
on a C57BL/6J background, were obtained from the Mutant 
Mouse Resource and Research Center (MMRC) catalogue 
number 049460-UCD, through the Jackson Laboratory. 
Deletion of Rin3 had been obtained by transfecting embry-
onic stem cells with the targeting vector containing a Veloci-
gene cassette (ZEN-Ub1). The targeting procedure generated 
mice with a 29.89Kb deletion at the Rin3 locus encom-
passing part of exon 1, all of exon 2 and most of exon 3 of 
Rin3. The Rin3−/− mice were crossed with 129P2OlaHsd 
mice obtained from Harlan UK to generate Rin3+/− hete-
rozygotes on a mixed C57BL/6J and 129P2OlaHsd genetic 
background. All experiments were performed on female 
Rin3−/− and wild-type littermates generated from mating of 
Rin3+/- heterozygotes. We confirmed that mRNA for Rin3 
was undetectable in lung tissue from Rin3−/− mice using 
qPCR, confirming that the targeted inactivation of Rin3 was 
successful (data not shown). The mice were housed in a des-
ignated animal facility in pathogen-free rooms maintained at 
constant temperature, with 12-h light/12-h dark cycles. They 
had free access to water and pelleted standard commercial 
diet (SDS, Special Diets Service). Mice were sacrificed by 
cervical dislocation or decapitation according to Schedule 
1 of the Animals (Scientific Procedures) Act. The sample 
size for the in vivo experiment was chosen to provide at least 
80% power to detect a 1.3 standard deviation difference in 
BV/TV between Rin3−/− and wild-type (WT) mice.
Analysis of Rin3 Gene Expression
In order to assess the efficiency of the targeted inactivation 
procedure, RNA was extracted from homogenised lung 
tissue of 7.5-week-old mice using TRizol® reagent (Invit-
rogen). Complementary DNA (cDNA) was transcribed by 
reverse transcription-polymerase chain reaction (RT-PCR) 
using the SuperScript III Reverse Transcriptase kit (Invit-
rogen). The expression Rin3 was assessed by quantitative 
PCR with the Roche universal library probe system (Roche). 
A FAM-labelled probe (#13, AGG CAG AG) was used with 
the following manually designed primers from the Ensembl 
Genome Browser: forward 5′-GCC GGT CCT ATT CCA GAT 
G-3′; Reverse 5′-AAG AAC TGA GCC TTC CAG GTA-3′. 
The reaction was performed using the SensiFAST Probe kit 
(Bioline) on a Chromo 4TM thermocycler (M J Research). 
The levels of Rin3 were normalised against eukaryotic 18S 
ribosomal RNA, which was detected using a VIC-labelled 
probe-primer (Applied Biosystems).
Transcriptome Analysis by RNA Sequencing
We evaluated global gene expression in bone marrow 
derived osteoclast cultures and primary calvarial osteoblast 
cultures derived from Rin3−/− and wild-type mice. The 
cultures were prepared from three mice of each genotype 
for each cell type and total RNA was extracted using TRi-
zol® reagent (Invitrogen). The TruSeq Stranded Total RNA 
library Gold prep kit (Illumina) was used for preparation 
of the cDNA library and sequencing was performed using 
an Illumina HiSeq 4000 75PE to yield 290 Million + 290 
Million reads per lane in 2 lanes. Full details of the methods 
used to process the data and to analyse gene expression are 
provided in the supplementary information.
MicroCT Analysis
Bone density and structure were analysed by micro com-
puted tomography (microCT) using a Skyscan 1172 instru-
ment (Bruker, Belgium). Prior to analysis, the bone sam-
ples were dissected free of soft tissue and fixed in 4% (v/v) 
paraformaldehyde in PBS overnight. The samples were then 
washed twice in PBS and stored at 4 °C in 70% (v/v) ethanol 
until scanning. Analysis of trabecular bone was performed 
by scanning the distal femoral and proximal tibial metaphy-
sis and the 6th lumbar vertebra. At the distal femoral meta-
physis, 450 slices were analysed in a region of interest 750 
µm from the growth plate. At the proximal tibial metaphy-
sis, 200 slices were analysed in a region of interest 500 µm 
from the growth plate. At lumbar vertebra, 200 slices were 
analysed 250 µm distally the transverse process. Analysis of 
cortical bone was performed on the femoral diaphysis only, 
where 200 slices were analysed 5 mm from the growth plate. 
The samples were scanned using an X-Ray source set at 60 
kV and 167 µA, a 0.5 mm aluminium filter and a resolution 
of 5 µm. The cross-section images were reconstructed using 
the NRecon system (Bruker, Belgium). The transaxial view 
of this model was then analysed with a free hand tracing tool 
at the region of interest, using the CTAn system (Bruker, 
Belgium). Both hind legs were used for the trabecular and 
cortical analyses.
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Bone Histomorphometry
Bone samples were processed and stained for histology using 
standard methods as previously described [12]. Briefly, ani-
mals received intraperitoneal injections of calcein 6 days and 
2 days before culling. The skin was removed, the bone sam-
ples were fixed for 24 h in 4% paraformaldehyde and stored 
at 4 °C in 70% ethanol until use. The samples were embed-
ded in methyl methacrylate and 5 µm sections were cut using 
a diamond knife. For analysis of bone resorption parameters, 
sections were stained for tartrate resistant acid phosphatase 
(TRAcP) to visualise osteoclasts and counterstained with 
aniline blue. For analysis of calcein double labelling, sec-
tions were counterstained with calcein blue. The bone sec-
tions were analysed using a Zeiss LSM800 (Carl Zeiss Ltd., 
UK) fluorescence microscope. Histomorphometric measure-
ments were performed using an open source software pro-
gramme [13] by an observer blinded to genotype.
Biochemical Markers
We measured serum levels of the procollagen I N-terminal 
propeptide (PINP) and the type I Collagen Cross-Linked 
C-Telopeptide (CTX-I) by enzyme-linked immunosorb-
ent assay using kits purchased from Immunodiagnostic 
Systems (IDS) (Boldon UK). Catalogue numbers were 
AC33F1 (PINP) and AC-06F (CTX-I) and they assays were 
run according to the manufacturer’s instructions. For both 
assays, values were recorded based on mean of the dupli-
cate samples and expressed in ng/ml by calibrating against 
a standard curve.
Osteoclast Cultures
Osteoclasts were generated from bone marrow cells flushed 
from the long bones of female mice aged between 9 and 
14 weeks. The marrow samples were cultured for 2 days 
in alpha-MEM supplemented with 1% L-Glutamine, 100 
U/ml penicillin, 100 μg/ml streptomycin, 10% foetal calf 
serum (Hyclone) and 100 ng/ml M-CSF (R&D systems 
Abingdon UK). Non-adherent cells were removed and the 
adherent macrophages were plated at 1 ×  104 cells in 96-well 
plates in the presence of 25 ng/ml M-CSF and 75 ng/ml 
RANKL (R&D Systems) for another 3 days. The medium 
was changed again in the same conditions and the cells were 
kept for another 24 h in the incubator. At the end of the cul-
ture period, the cells were fixed in 4% paraformaldehyde and 
stained for TRAcP according to standard techniques. Cells 
with at least three nuclei that stained positive for TRAcP 
were counted as osteoclasts. Osteoclasts that contained ≥10 
nuclei were considered to be large osteoclasts.
We also studied osteoclast survival in the same cultures. 
For this assay, RANKL was added at a reduced concentration 
of 25 ng/ml for the last 4 days of the culture and then the 
medium was replaced with standard culture medium without 
RANKL. The cultures continued for up to 72 h from when 
the cells were fixed, then stained for TRAcP and counted as 
described above.
Osteoblast Cultures
Primary osteoblasts were isolated from the calvarial bones 
of 2-day-old mice using sequential collagenase digestion 
as previously described [14]. The cells were cultured in 
75  cm2 flasks in standard alpha-MEM supplemented with 
10% foetal bovine serum and left to adhere overnight. To 
measure the activity of alkaline phosphatase (ALP), the 
osteoblasts were passaged using trypsin and seeded into 
96-well plates at a density of 8 ×  103 cells per well. The 
cells were cultured for 7 days and the experiment was 
terminated by the addition of lysis buffer containing 1M 
diethanolamine, 1 mM  MgCl2, and 0.05% Triton X100. 
The ALP activity was assessed on cell lysates using a 
colorimetric assay based on conversion of p-nitrophenyl 
phosphate to p-nitrophenol using a plate-reader set at an 
absorbance of 405 nm. Activity of ALP was corrected for 
cell number following staining with 10% Alamar blue rea-
gent (v/v) as described [15]. We also assessed formation 
of mineralised bone nodules using calvarial osteoblast cul-
tures. For this assay, the osteoblasts were plated in 12-well 
plates at a density of 1 ×  105 cells per well and cultured 
for 21 days in osteogenic media as described [15]. At the 
end of the culture period, cell viability was assessed using 
staining with 10% Alamar blue reagent (v/v). The cells 
were then fixed in 70% ethanol, washed in PBS, briefly 
stained with alizarin red and left to dry overnight. The 
nodules were quantified by destaining the cultures in a 
10% (w/v) cetylpyridinium chloride solution prepared in 
10mM sodium phosphate (pH 7.0) and measuring absorb-
ance of the extracted stain by spectrophotometry as previ-
ously described [16]. The absorbance was measured at 562 
nm and compared to a standard curve. The values were 
corrected for cell number as assessed by alamar blue stain-
ing. All colorimetric and fluorescent measures were done 
using the BioTek Synergy HT plate reader (BioTek, UK).
Statistical Analysis
Differences between genotype groups for continuous vari-
ables were assessed by t test for independent samples in indi-
vidual experiments. For the cell culture experiments a gen-
eral linear model analysis of variance was used to study the 
effect of time and genotype in which all the replicates within 
individual experiments were combined. For this analysis, the 
variable of interest (osteoclast number, alizarin red staining, 
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alkaline phosphatase) was selected as the dependent vari-
able and (where relevant) time, experiment and genotype 
entered as the explanatory variables. Statistical analysis was 
performed using SPSS version 22 or Minitab version 18. A 
p value of less than 0.05 was considered to be statistically 
significant.
Results
General Appearance and Body Weight
The Rin3−/− mice were of similar appearance to wild-type 
littermates and had a similar body weight at 8 weeks of age 
(Rin3−/− vs. WT (mean ± SD) = 20.8 ± 2.4 vs. 21.3 ± 1.5 
g, p = 0.59) and 52 weeks of age (34.1 ± 4.6 vs. 33.4 ± 1.5 
g, p = 0.60).
MicroCT Analysis
The results of microCT analysis of trabecular bone at the 
femoral metaphysis in 8-week and 52-week-old mice are 
shown in Table 1. Trabecular bone volume (BV/TV) and 
trabecular number were significantly higher at the femoral 
metaphysis of Rin3−/− mice at 8 weeks of age compared with 
wild-type littermates. Trabecular thickness did not differ 
between genotypes, but trabecular separation and trabecular 
patterning factor were both lower in the Rin3−/− mice as 
compared with wild type. At 52 weeks, the difference 
between genotypes was even more pronounced with sub-
stantially higher BV/TV in the Rin3−/− mice compared to 
the wild-type littermates. Similar findings were observed at 
both 8 weeks and 52 weeks at the proximal tibial metaphysis 
(supplementary information Table S1). Analysis of cortical 
bone at the femoral diaphysis showed that there was no sig-
nificant difference in cortical bone mass or structure between 
Rin3−/− mice and wild-type littermates, except at 52 weeks 
where the marrow diameter was significantly smaller in 
Rin3−/− mice compared with wild-type littermates (Table 2). 
Representative microCT images from the distal femoral met-
aphysis and the femoral diaphysis in Rin3−/− mice and wild-
type littermates at 8 weeks are shown in Fig. 1. In contrast to 
findings in the limbs, there were no differences in trabecular 
bone volume or other parameters at the lumbar vertebra 6 in 
both age groups of Rin3−/− mice compared with wild type 
(supplementary information Table S2).
Bone Histomorphometry
The results of bone histomorphometry are shown in Table 3. 
Osteoclast surface expressed as a percentage of bone sur-
face (Os.S/BS) was significantly reduced in 8-week-old 
Rin3−/− mice compared with wild-type littermates. A similar 
trend was observed for the number of osteoclasts per unit of 
bone surface (N.Oc/BS) and for the number of osteoclasts 
Table 1  MicroCT analysis of trabecular bone from the distal femoral metaphysis in Rin3−/− and wild-type mice
BV/TV bone volume/tissue volume, Tb.Th trabecular thickness, Tb.Sp trabecular separation, Tb.N trabecular number, Tb.Pf trabecular pattern 
factor. The values shown are the mean ± SD values. The p values refer to differences between genotype groups
8 weeks 52 weeks
Wild type (n = 11) Rin3−/− (n = 14) p value Wild type (n = 11) Rin3−/− (n = 10) p value
BV/TV (%) 7.0 ± 1.5 9.0 ± 2.5 0.002 8.5± 4.2 15.8 ± 9.5 0.002
Tb.Th (µm) 37.8 ± 1.9 37.2 ± 2.7 0.405 44.2 ± 6.8 47.6 ± 7.1 0.117
Tb.Sp (µm) 261.4 ± 27.7 234.7 ± 26.8 0.001 346.9 ± 93.8 262.0 ± 97.8 0.007
Tb.N (1/mm) 1.85 ± 0.4 2.38 ± 0.5 < 0.001 1.89 ± 0.96 3.22 ± 1.80 0.006
Tb.Pf (1/µm) 0.033 ± 0.00 0.029 ± 0.00 0.002 0.018 ± 0.01 0.014 ± 0.01 0.036
Table 2  MicroCT analysis of cortical bone from the femoral diaphysis in Rin3−/− and wild-type mice
Ct.Dm cortical diameter, BV bone volume, Ct.Th cortical thickness, Ma.Dm marrow diameter. The values shown are the mean ± SD values from 
both limbs combined. The p values refer to the difference between genotype groups
8 weeks 52 weeks
Wild type (n = 11) Rin3−/− (n = 14) p value Wild type (n = 11) Rin3−/− (n = 10) p value
Ct.Dm (mm) 1.56 ± 0.06 1.55 ± 0.08 0.709 1.80 ± 0.10 1.81 ± 0.10 0.787
BV (µm3 ×  108) 7.52 ± 0.55 7.53 ± 0.82 0.959 15.4 ± 2.50 16.4 ± 2.20 0.185
Ct.Th (µm) 179.5 ± 10.2 180.8 ± 14.3 0.714 307.4 ± 47.4 319.4 ± 33.1 0.344
Ma.Dm (mm) 0.84 ± 0.05 0.82 ± 0.07 0.340 0.57 ± 0.20 0.43 ± 0.10 0.001
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per unit of bone volume (N.Oc/BV), but the differences 
were not significant for these variables. At 52 weeks, Oc.S/
BS, N.Oc/BS and N.Oc/BV were numerically lower in 
Rin3−/− mice compared wild-type littermates but there was 
considerable variation and the differences between geno-
types was not significant. Mineral apposition rate (MAR) 
did not significantly differ between genotypes at either 8 
weeks or 52 weeks. The perimeter of bone surfaces occupied 
by single labels (sL.Pm/B.Pm) was significantly higher in 
Rin3−/− mice at 52 weeks. Representative photomicrographs 
of trabecular bone from 8-week-old and 52-week-old mice 
are shown in Fig. 2 which illustrates the difference between 
genotypes in trabecular bone volume throughout life, the 
relative reduction in osteoclast surfaces in Rin3−/− mice 
compared to wild type at 8 weeks of age and the relative 
increase in single labelled surfaces compared to wild type 
in Rin3−/− mice at 52 weeks of age.
Biochemical Markers
We found no significant differences between genotype 
groups in serum concentrations of either PINP or CTX-I 
values at either 8 weeks or 52 weeks of age. Circulating 
concentrations of PINP fell significantly with age between 
8 weeks and 52 weeks in both genotype groups (both p < 
0.001). Concentrations of CTX-1 also fell with age and this 
was significant in the Rin3−/− mice (p = 0.03) but not in the 
wild-type mice (p = 0.45) (Table 4).
Osteoclast and Osteoblast Cultures
We found no differences in M-CSF and RANKL-induced 
osteoclast formation in cultures prepared from Rin3−/− and 
wild-type littermates either in terms of total osteoclasts or large 
osteoclasts with more than ten nuclei (Fig. 3a). There was also 
no difference between genotype groups in osteoclast survival 
Fig. 1  Representative microCT images from Rin3−/− and wild-type 
mice. Panel a trabecular bone in distal femoral metaphysis from wild-
type mice (WT); Panel b trabecular bone from distal femoral meta-
physis Rin3−/− mice; Panel c cortical bone from femoral diaphysis 
in wild-type mice; Panel d: cortical bone from femoral diaphysis in 
Rin3−/− mice. The microCT images are from 8-week-old mice
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after withdrawal of RANKL (Fig. 3b). Mineralised nodule for-
mation was slightly but significantly increased in Rin3−/− com-
pared with wild-type mice when data from all experiments 
were combined (Fig. 4). There was no significant difference in 
alkaline phosphatase activity in calvarial osteoblasts isolated 
from Rin3−/− and wild-type mice (data not shown).
Transcriptome Analysis
Results of the transcriptome analysis assessed by RNA 
sequencing are summarised in supplementary Fig. S1 and 
supplementary Table S4. We identified eight transcripts from 
seven genes that were differentially expressed in calvarial oste-
oblasts cultured from Rin3−/− and wild-type mice. Only two 
of the transcripts are known to have a role in bone metabolism 
and both were upregulated in Rin3−/− mice (Sfrp2 and Dlk1). 
The SFPR2 gene has been implicated in syndactyly and brach-
ydactyly in humans [17] but the increased levels of expres-
sion seem unlikely to contribute to the phenotype observed 
in Rin3−/− mice. The Dlk1 gene is a member of the Notch 
family which has been implicated as a paracrine and endocrine 
regulator of bone mass which inhibits osteoblast differentia-
tion [18]. The upregulation of this gene also seems unlikely 
to contribute to the skeletal phenotype in Rin3−/− mice. We 
observed no significant differences in patterns of gene expres-
sion in osteoclasts generated from bone marrow macrophages 
between Rin3−/− and wild-type mice when the data were cor-
rected for multiple testing.
Discussion
The RIN3 gene was identified as a candidate for susceptibil-
ity to PDB by an extended genome-wide association study 
[2]. The strongest association was with rs10498635 [2] 
which is in strong linkage disequilibrium with rs117068593, 
a common missense variant that encodes an arginine to 
cysteine amino acid substitution at codon 297 (p.R279C) 
in exon 6 of RIN3 [8]. Targeted sequencing of RIN3 subse-
quently identified thirteen missense variants within the same 
haplotype block as rs117068593 which, when combined, 
were strongly over-represented in PDB cases as compared 
with controls with an odds ratio of greater than 3 [8]. A fur-
ther study confirmed the association between the common 
p.R279C variant and PDB in Belgian and Dutch patients and 
identified six further rare missense variants and PDB [9]. In 
both studies, in silico analysis indicated that p.R279C and 
many of the rare missense variants were likely to affect pro-
tein function, but it remains unclear at present whether they 
inhibit or enhance the ability of RIN3 to act as a guanine 
exchange factor.
The results of the present study are of interest in confirm-
ing that RIN3 plays an important role in regulating bone 
metabolism, further supporting the candidacy of this gene 
as a cause of PDB. Trabecular bone volume and trabecu-
lar numbers were substantially higher in Rin3−/− mice at 8 
weeks of age as compared with wild-type littermates and 
the difference between genotypes was even greater in mice 
aged 52 weeks. The increase in penetrance of the pheno-
type with ageing is of interest in relation to the fact that 
PDB increases in prevalence with age in humans [19]. It 
is also consistent with observations in the P394L mouse 
model of PDB where the phenotype worsened with age 
and was fully penetrant in 52-week-old mice [20]. Histo-
morphometric analysis revealed that this was associated 
with significantly lower osteoclast surfaces at 8 weeks and 
significantly higher perimeter occupied by single calcein 
labels at 52 weeks. It is important to emphasise, however, 
that the differences between genotypes in these parameters 
were modest and there was no difference between genotype 
Table 3  Bone histomorphometry in Rin3−/− and wild-type mice
Oc.S/BS osteoclast surface/bone surface, N.Oc/BS number of osteoclasts/bone surface, N.Oc/BV number of osteoclasts/bone volume, MS/BS 
mineralising surface/bone surface, sL.Pm single label perimeter, dL.Pm double label perimeter, MAR mineral apposition rate, BFR/BS bone for-
mation rate/bone surface. The values shown are the mean ± SD values. The p values refer to the difference between genotype groups. Note that 
for 8-week-old mice data on bone formation parameters were available on 9 Rin3−/− mice
8 weeks 52 weeks
Wild type (n = 10) Rin3−/− (n = 13) p value Wild type (n = 12) Rin3−/− (n = 11) p value
Oc.S/BS (%) 29.7 ± 6.6 24.1 ± 4.7 0.025 18.2 ± 5.4 16.2 ± 5.8 0.396
N.Oc/BS  (mm−1) 12.7 ± 2.7 11.4 ± 2.0 0.221 9.4 ± 2.7 8.4 ± 2.9 0.409
N.Oc/BV  (mm−2) 845 ± 251 685 ± 172 0.085 432 ± 141 374 ± 185 0.409
MS/BS (%) 38.2 ± 2.7 39.8 ± 5.6 0.436 44.0 ± 4.5 46.9 ± 4.2 0.129
sL.Pm/B.Pm (%) 23.6 ± 4.7 26.9 ± 6.4 0.223 16.5 ± 3.8 24.4 ± 6.4 0.003
dL.Pm/B.Pm (%) 26.3 ± 4.4 26.4 ± 8.3 0.976 35.6 ± 5.5 34.7 ± 5.9 0.719
MAR (µm/day) 1.25 ± 0.20 1.12 ± 0.08 0.091 1.83 ± 0.25 1.67 ± 0.14 0.080
BFR/BS (µm3/µm2/day) 0.48 ± 0.08 0.45 ± 0.08 0.425 0.81 ± 0.18 0.79 ± 0.10 0.668
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groups in osteoclast numbers expressed as a function of bone 
surface or bone volume, mineral apposition rate, bone for-
mation rate, or double labelled calcein perimeter at either 
time point. While analysis of biochemical markers of bone 
resorption and formation at both 8 weeks and 52 weeks 
did not reveal a significant difference between groups, the 
microCT data coupled with the histomorphometry data do 
indicate that deficiency of Rin3 causes a relative uncoupling 
Fig. 2  Representative bone 
histology from Rin3−/− and 
wild-type mice at aged 8 weeks 
panels a–d and 52 weeks (Pan-
els e–h). Calcein labelling (light 
green) in panels a, b, e and f has 
been visualised under polarised 
light. Panels c, d, g and h have 
been stained with aniline blue 
and counterstained for tartrate 
resistant acid phosphatase (red). 
Higher magnification images 
of the sections are shown in the 
bottom left of each panel and 
the area from which the images 
are taken are indicated by 
squares with interrupted lines. 
The black circles in sections c, 
d and h are air bubbles in the 
fixative
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of bone resorption and formation which operates throughout 
life to cause a markedly increased trabecular bone mass in 
older mice.
Although trabecular bone mass was markedly higher 
in Rin3−/− mice, we observed no difference between 
genotypes in terms of cortical bone parameters except at 
52 weeks where the medullary cavity diameter was smaller 
in Rin3−/− mice compared with wild type, which would be 
consistent with lower rates of endosteal bone resorption. The 
contrasting effects of Rin3 deficiency on trabecular bone 
phenotype versus cortical bone are unexplained at present, 
but this finding is not infrequent in mice with targeted inac-
tivation of genes presumably due to site-specific effects of 
their products on bone metabolism [21–23].
We also studied osteoclast differentiation and osteoclast 
survival in vitro but found no significant differences between 
genotypes. This is consistent with a model whereby the high 
bone mass and reduced osteoclast surfaces in Rin3−/− mice 
were due to a decrease in the amount of bone resorbed per 
osteoclast rather than by an effect on osteoclast differentia-
tion or survival. The phenotype in Rin3−/− mice is of interest 
in relation to previous studies by Pavlos and colleagues [24] 
who conducted phenotyping of mice with targeted inactiva-
tion of the small GTPase Rab3D, which is a potential target 
for RIN3. In this study [24], osteoclast differentiation was 
normal in vitro, but trabecular bone mass was increased 
in vivo as reported here and this was accompanied by a 
reduction in eroded surface. In the Pavlos study, it was also 
of interest that osteoclasts derived from mice with Rab3D 
deficiency had a defect in resorptive function which was 
thought to account for the phenotype observed. We did not 
have the opportunity to study bone resorption by isolated 
osteoclasts in Rin3−/− mice which is a limitation of the pre-
sent study, but this work is being planned in the coming 
months in order to gain greater insight into the role of Rin3 
in osteoclast function and bone metabolism. Given that 
PDB is characterised by increased osteoclast activity and 
bone resorption, the phenotype we observed in Rin3−/− mice 
suggests that the missense genetic variants in RIN3 that are 
associated with PDB may exert gain-of-function effects on 
bone resorption although more work will be required to con-
firm this.
Until now, the role of Rin3 in bone metabolism has been 
little studied. It is recognised that Rin3 acts as a guanine 
exchange factor (GEF) for several members of the Rab5 
subfamily of GTPases [7, 25, 26]. The Rab proteins play an 
important role in membrane trafficking in several cell types, 
and studies by Zhao and colleagues have shown that osteo-
clasts express many different Rab proteins [10]. There is 
Table 4  Biochemical markers in Rin3−/− and wild-type mice
The values shown are the mean ± SD values. The p values refer to the difference between genotype groups
8 weeks 52 weeks
Wild type (n = 10) Rin3−/− (n = 12) p value Wild type (n = 9) Rin3−/− (n = 9) p value
PINP (ng/ml) 8.4 ± 2.2 8.6 ± 2.5 0.584 2.8 ± 1.3 1.5 ± 1.1 0.093
CTX-I (ng/ml) 21.1 ± 5.6 20.1 ± 3.8 0.602 18.5 ± 9.0 13.6 ± 7.4 0.221
Fig. 3  Osteoclast formation and survival in Rin3−/− and wild-type 
mice. Panel a: Osteoclast cultures from wild-type (WT) and Rin3−/− 
mice, showing total osteoclasts and large osteoclasts (≥ 10 nuclei); 
Panel b: Osteoclast survival following RANKL withdrawal in wild-
type (WT) and Rin3−/− mice. There were no significant differences 
between genotypes, either in osteoclast formation, formation of large 
osteoclasts or in osteoclast survival at any timepoint. The columns are 
least square means and bars are standard deviation of the mean for 
five separate experiments for osteoclast formation and for three sepa-
rate experiments for osteoclast survival
Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption…
1 3
experimental evidence to show that Rab3D [24] and Rab7 
[27] both play a role in osteoclastic bone resorption, but it 
remains unclear if Rin3 acts as a GEF for these Rab family 
members. It is similarly unclear to what extent the Rab5 sub-
family members regulate osteoclast function and further work 
will be required to investigate the targets for Rin3 in osteoclasts 
and the mechanisms by which it affects osteoclast function.
The studies reported here are also of interest in relation to 
the work of Kemp and co-workers who identified RIN3 as a 
significant determinant of lower-limb BMD in children [28]. 
In Kemp’s study, higher BMD values in the lower limbs 
were associated with the rs754388 variant at genome-wide 
significant level. The rs754388 variant is in strong link-
age disequilibrium with the same direction of effect as the 
variants that we previously reported to be associated with 
PDB [8]. At first sight, it seems counter-intuitive that vari-
ants associated with a condition characterised by increased 
osteoclast activity might also be associated with high bone 
mass in children, but it is possible to speculate that positive 
coupling between bone resorption and formation during the 
high turnover state that is characteristic of a growing skel-
eton could account for this finding. In this regard, variants 
at the RIN3 locus do not appear to be associated with BMD 
as assessed by DEXA in adults [29] or with heel ultrasound 
properties of bone [30] at a genome-wide significant level.
In conclusion, the present studies confirm that Rin3 regu-
lates bone mass and bone metabolism in mice with effects 
on cells of both the osteoclast and the osteoblast lineage, 
confirming the importance of guanine exchange factors 
and their targets in regulation of skeletal homeostasis. Our 
observations also suggest that the variants that predispose to 
Paget’s disease of bone in humans probably do so by causing 
a gain-in-function of RIN3, but further work will need to be 
performed to define the molecular mechanisms by which 
Rin3 affects bone cell activity.
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